Arbutus Biopharma Corporation

NASDAQ:ABUS

Biotechnology

Healthcare
$4.07 +1.13%

+$0.05 today

Market cap
$623.90M
Beta
0.63
P/E (TTM)
5.4
EPS (TTM)
$0.83
52W Low $3.04High $5.10

Volume 2.44M

Average 1.76M

Balance Sheet

Inspect the capital base behind the business.

Assets

$94.62M

FY 2025 · Annual

-28.2% YoY

Liabilities

$18.04M

FY 2025 · Annual

-47.5% YoY

Equity

$76.58M

FY 2025 · Annual

-21.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents109.28M30.78M26.29M36.33M18.01M
Short-term Investments46.04M116.14M99.72M86.29M73.46M
Net Receivables899K1.35M1.78M2.41M1.75M
Inventory00000
Other Current Assets02.87M4.25M2.28M1.24M
Total Current Assets160.66M151.14M132.03M127.32M94.46M
Property, Plant & Equipment (Net)8.07M6.81M6.09M4.36M32K
Goodwill00000
Intangible Assets00000
Long-term Investments35.69M37.36M6.28M00
Tax Assets00000
Other Non-current Assets61K103K034K130K
Total Non-current Assets43.82M44.28M12.37M4.39M162K
Total Assets204.49M195.42M144.4M131.71M94.62M
Account Payables3.17M3.52M3.22M2.32M1.17M
Short-term Debt383K372K00547K
Tax Payables00000
Deferred Revenue016.46M11.79M7.57M0
Other Current Liabilities3.39M8.78M3.7M02.13M
Total Current Liabilities11.22M32.86M22.49M15.62M6.01M
Long-term Debt16.3M10.37M6.95M4.83M3.44M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)06M02.86M0
Other Non-current Liabilities5.3M7.53M7.6M10.23M8.4M
Total Non-current Liabilities23.83M25.71M15.9M18.72M12.04M
Total Liabilities35.05M58.57M38.38M34.34M18.04M
Common Stock1.29B1.32B1.35B1.41B1.42B
Retained Earnings(1.13B)(1.2B)(1.28B)(1.35B)(1.38B)
Accumulated OCI(48.33M)(50.49M)(48.42M)(48.14M)(48.1M)
Other Stockholders Equity(1)0000
Minority Interest00000
Total Equity169.44M136.85M106.02M97.37M76.58M
Total Debt18.91M12.55M8.72M6.12M4.19M
Net Debt(90.37M)(18.22M)(17.56M)(30.21M)(13.82M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$23.7M
Short-term Investments$71.5M
Receivables$1.3M
Other Current$180.5M
Total Current Assets$277.0M
PP&E (Net)$22.0K
Other Non-current$131.0K
Total Non-current Assets$153.0K
Total Assets$277.2M

Analysis

Selected assets total $277.2M for Latest. The largest visible component is Other Current at $180.5M, about 65.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 10, 2026
8-KCurrent reportNov 10, 2026
SC 13G/ASC 13G/A filingOct 27, 2026
8-KCurrent reportOct 22, 2026

How much cash does ABUS have?

Arbutus Biopharma Corporation (ABUS) reported $18.01M in cash and equivalents in fiscal 2025.

How much debt does ABUS carry?

Arbutus Biopharma Corporation (ABUS) reported $4.19M of total debt, with net debt of -$13.82M.